Abstract

The human insulin-like growth factor-II (IGF-II) gene transcribes four mRNAs (P1 mRNA-P4 mRNA), and P3 mRNA overexpression contributes to hepatocarcinogenesis. IGF-II-derived miR-483-5p is implicated in the development of cancers. Here, we investigated the involvement of miR-483-5p in P3 mRNA overexpression regulation and its role in hepatocellular carcinoma. Our results showed that miR-483-5p up-regulated P3 mRNA transcription by targeting the 5′-untranslated region (5′UTR) of P3 mRNA in hepatocellular carcinoma. The mechanism was involved in recruiting of an argonaute 1(Ago1)-argonaute 2 (Ago2) complex to the P3 mRNA 5′UTR and the P3 promoter of IGF-II gene by miR-483-5p, accompanied by increased enrichment of RNA polymerase II and activating histone marks histone 3 lysine 4 trimethylation (H3K4me3), histone 3 lysine 27 acetylation (H3K27ac), and histone 4 lysine 5/8/12/16 acetylation (H4Kac) at the P3 promoter. High miR-483-5p expression was an independent predictor for shorter survival of HCC patients. The findings suggest that miR-483-5p promotes P3 mRNA transcription by recruiting the Ago1-Ago2 complex to the P3 mRNA 5′UTR and is associated with poor prognosis of HCC. Our results display a potential new model for miRNAs to up-regulate gene expression.

Highlights

  • The human insulin-like growth factor-RNA polymerase II (II) (IGF-II) is a fetal growth factor that is involved in fetal growth and development [1]

  • To investigate that if miRNAs are involved in increased P3 messenger RNA (mRNA) expression in hepatocellular carcinoma (HCC), we predicted candidate miRNAs targeting the P3 mRNA 5′-untranslated region (5′UTR) (NM_000612) only, that is to say, they do not bind to the 3′UTR and 5′UTR of the other three transcrips, P1-P4 promoters, and insulin-like growth factor-II (IGF-II) protein coding region of IGFII gene using RegRNA

  • We identified 70 miRNA candidates (Supplementary Table 1) and the top five miRNAs with a remarkable minimal free energy value were selected for further validation. Quantitative RT-PCR (qRT-PCR) analysis showed that only miR-483-5p expression was up-regulated in human HCC cell lines (Huh7, Hep3B, Bel-7402, HepG2, SMMC-7721) compared with the normal human liver cell line (HL-7702), and the expression level of P3 mRNA and miR-483-5p was positively correlated in the above HCC cell lines (r = 0.960, P = 0.01) (Figure 1A)

Read more

Summary

Introduction

The human insulin-like growth factor-II (IGF-II) is a fetal growth factor that is involved in fetal growth and development [1]. The gene encoding IGF-II contains nine exons and four promoters (P1–P4), and each of these promoters initiates distinct transcription, yielding a promoter-specific transcript (P1 mRNA-P4 mRNA) that has a unique 5′-untranslated region (5′UTR) and an identical 3′UTR [2]. IGF-II is expressed predominantly in fetal liver under physiological conditions through the activation of P2-P4 promoters; its expression is significantly down-regulated shortly after birth because of remarkable decrease or loss of the activity of P2–P4 promoters [3]. Increased level of IGF-II in HCC results mainly from the transcriptional up-regulation of P3 www.impactjournals.com/oncotarget mRNA and P4 mRNA [9, 10]. The reasons and mechanisms responsible for the reactivation of the two fetal transcripts are not well clarified

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call